The main goal of the Survey Research Core (SRC), located at the AMC Cancer Research Center, is to provide technical assistance and services to UCCC members in collecting research data, with specialized expertise in computer-assisted telephone interviews (CATI). The SRC collaborates in testing the effectiveness of cancer related health education and behavioral interventions delivered by telephone. Since its inception as a UCCC Core resource in the Year 2000, the SRC has shown sustained growth in utilization, providing support to 20 peer-reviewed cancer-related studies conducted by 12 different Principal Investigators affiliated with the UCCC. In these studies the SRC has conducted over 26,000 cancer-related telephone interviews. The number of cancer-related interviews completed by the SRC in Year 2004 exceeded 10,000, representing a 14-fold increase in utilization compared to the Year 2000. In the current operating budget the SRC gets 28% of its funding from the UCCC as a core resource, 55% from grants and contracts, and 17% from other UCCC institutional resources (Cancer Center gift funds and institutional support from AMC, a Consortium Cancer Center member institution). UCCC core funds provide partial support for consultation services, management, and oversight of this resource. All interviewer positions are 100% funded by grants and contracts. Future plans include: 1. expanding utilization of the SRC by UCCC members across a broader range of program areas (e.g. by using the SRC to conduct follow-up of patients in clinical trials) 2. using the SRC to test telephone education and counseling interventions across the full spectrum of cancer prevention and control 3. using the SRC to develop and test telephone-delivered patient navigation, support and referral interventions 4. expanding SRC capacity to conduct web-based surveys and interventions.

Agency
National Institute of Health (NIH)
Institute
National Cancer Institute (NCI)
Type
Center Core Grants (P30)
Project #
3P30CA046934-25S2
Application #
8710582
Study Section
Subcommittee G - Education (NCI)
Project Start
Project End
Budget Start
2013-02-01
Budget End
2014-01-31
Support Year
25
Fiscal Year
2013
Total Cost
$961
Indirect Cost
$339
Name
University of Colorado Denver
Department
Type
DUNS #
041096314
City
Aurora
State
CO
Country
United States
Zip Code
80045
Kim, Seongsoon; Park, Donghyeon; Choi, Yonghwa et al. (2018) A Pilot Study of Biomedical Text Comprehension using an Attention-Based Deep Neural Reader: Design and Experimental Analysis. JMIR Med Inform 6:e2
Altieri, Lisa; Miller, Kimberly A; Huh, Jimi et al. (2018) Prevalence of sun protection behaviors in Hispanic youth residing in a high ultraviolet light environment. Pediatr Dermatol 35:e52-e54
Kwak, Jeff W; Laskowski, Jennifer; Li, Howard Y et al. (2018) Complement Activation via a C3a Receptor Pathway Alters CD4+ T Lymphocytes and Mediates Lung Cancer Progression. Cancer Res 78:143-156
Hoefert, Jaimee E; Bjerke, Glen A; Wang, Dongmei et al. (2018) The microRNA-200 family coordinately regulates cell adhesion and proliferation in hair morphogenesis. J Cell Biol 217:2185-2204
Riemondy, Kent A; Gillen, Austin E; White, Emily A et al. (2018) Dynamic temperature-sensitive A-to-I RNA editing in the brain of a heterothermic mammal during hibernation. RNA 24:1481-1495
Sclafani, Robert A; Hesselberth, Jay R (2018) O Cdc7 kinase where art thou? Curr Genet 64:677-680
Shearn, Colin T; Orlicky, David J; Petersen, Dennis R (2018) Dysregulation of antioxidant responses in patients diagnosed with concomitant Primary Sclerosing Cholangitis/Inflammatory Bowel Disease. Exp Mol Pathol 104:1-8
Kim, Jihye; Yoo, Minjae; Shin, Jimin et al. (2018) Systems Pharmacology-Based Approach of Connecting Disease Genes in Genome-Wide Association Studies with Traditional Chinese Medicine. Int J Genomics 2018:7697356
Coleman, Carrie B; Lang, Julie; Sweet, Lydia A et al. (2018) Epstein-Barr Virus Type 2 Infects T Cells and Induces B Cell Lymphomagenesis in Humanized Mice. J Virol 92:
Petersen, Dennis R; Orlicky, David J; Roede, James R et al. (2018) Aberrant expression of redox regulatory proteins in patients with concomitant primary Sclerosing cholangitis/inflammatory bowel disease. Exp Mol Pathol 105:32-36

Showing the most recent 10 out of 1634 publications